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Abstracts 395neurologic events included 2 major and one minor stroke (11%). Transient
spinal cord ischemia with full recovery was observed in 2 patients (7%). One
myocardial infarction required medical treatment (4%) and 2 renal function
impairment (7%) were depicted. Early (<30 day) re-interventions (11%)
were performed to treat one access complication, one left ventricle false
aneurysm suspicion and one limb ischemia. During follow up (median 12
months), 1 patient (4%) died from a remote TAAA rupture. Two type 2 (7%)
and one type 3 endoleaks (4%) were depicted. During follow up, 2 (7%) re-
interventions were performed to treat the type 3 endoleak and a septic
aortic false aneurysm.
Conclusion: The outcomes associated with this new technique are
favourable when the procedure is performed in experienced centres.
Branched endografting of arch aneurysms should be considered in patients
unﬁt for open surgery.
Long-term Survival after TEVAR depends on Indication for
Surgery, and is Shorter than Expected after Ruptured Thoracic
Aneurysm
T. Hellgren, A. Wanhainen, M. Björck, K. Mani
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University
Hospital, Sweden
Introduction: Thoracic endovascular aortic repair (TEVAR) is used in
treatment of type B aortic dissections and descending aortic aneurysms
increasingly often. TEVAR is associated with lower peri-operative mortality
when compared to open surgery in retrospective studies. We assessed
long-term survival after TEVAR depending on diagnosis.
Methods: All patients who underwent TEVAR for type B aortic dissec-
tion or thoracic aortic aneurysm at Uppsala University Hospital between
December 1999 and December 2013 were included. Traumatic aortic
transections, thoraco-abdominal- and mycotic aneurysms, as well as type A
dissections were not included. Patient characteristics and survival data
were collected from medical records. 30 day survival was analyzed with
chi2 and 5 year survival was estimated with Kaplan-Meier. Age-adjusted
survival was estimated with a Cox regression analysis.
Results: Of the 250 patients who underwent TEVAR, 190 were included
(excluded: traumatic transections n ¼ 17, thoraco-abdominal hybrid pro-
cedures n ¼ 20, mycotic aneurysms n ¼ 5, type A dissections n ¼ 8, others
n ¼ 10). Diagnosis distribution was acute type B aortic dissection (ABAD)
n¼ 63; chronic typeB aortic dissection (CBAD) n¼ 45; intact aneurysm (iTAA)
n ¼ 57 and ruptured aneurysm (rTAA) n ¼ 25. Mean follow up was 49
months. Mean age of the patients was ABAD 66.5 years; CBAD 61.9; iTAA
71.6; rTAA 74.5 (p< 0.001).The male to female ratio was ABAD 41:22; CBAD
34:11, iTAA 34:23, rTAA 12:13 (p¼ 0.132). 30 day survival was ABAD 92.1%;
CBAD 95.6%; iTAA 96.5%; rTAA 72.0% (p¼ 0.002). 5 year survival was ABAD
79.2%; CBAD 79.6%; iTAA 66.0%; no patient with 5 year follow up after rTAA
was alive, and 3 year survival was 30.8%, see attached ﬁgure (Log-Rank
p< 0.001). In a Cox regression analysis of mid-term survival for patients who
survived the initial 30 day peri-operative period, age-adjusted hazard ratio for
death was 5.7 after rTAA compared to the other diagnoses.
Conclusion: Long-term survival after TEVAR was adequate for patients
with type B aortic dissection and intact aortic aneurysm. Considering the
poor long-term survival after TEVAR for ruptured aortic aneurysm, it may
be necessary to be more selective when deciding which of these patients
who beneﬁt from active treatment.
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Introduction: Renal failure is a signiﬁcant source of morbidity and mortality
in patients who require thoraco-abdominal (TAA) aortic repair. We
reviewed our 25 year experience with open descending thoracic and
thoraco-abdominal repair to identify risk factors for and potential thera-
peutic targets to prevent renal failure.Methods: We performed 1896 operations in 1795 patients. The ma-
jority of cases were performed using cerebrospinal ﬂuid drainage and
distal aortic perfusion, and visceral perfusion was used selectively in
patients with repairs that involved the origins of the celiac, superior
mesenteric and renal arteries. Renal failure was deﬁned as new-onset
renal dysfunction in patients without existing chronic renal disease, and
included an increase in post-op creatinine >1 mg/dl/day over the ﬁrst
two post-op days, an absolute creatinine >4 mg/dl or need for dialysis.
Multivariable statistics were used to assess pre-and intra-operative risk
factors for renal dysfunction, and the effect of renal morbidity on long-
term survival was evaluated by Kaplan-Meier analysis.
Results: Mean population age was 64.2 +/- 13.9, and 669/1795 (37%)
patients were female. Renal dysfunction occurred after 488/1896 (25.7%)
operations. Multivariable pre-operative predictors of post-operative renal
failure were patient age (OR 1.03/yr, p < 0.0001), TAA extent 1 (OR 2.02,
p < 0.0001), TAA2 (OR 5.9, p < 0.0001), TAA3 (OR 4.2, p < 0.0001), TAA4
(OR 2.9, p < 0.0001), emergency presentation (OR 1.4, p < 0.04) and
coronary artery disease (CAD; OR 1.3, p < 0.04). Addition of intra-operative
variables identiﬁed patient age (OR 1.03/yr, p < 0.0001), aortic dissection
(OR 0.62, p < 0.002), involvement of the aortic segment containing the
visceral vessel origins (OR 1.5, p < 0.005), COPD (OR 1.3, p < 0.02), aortic
cross clamp time (OR1.02/min, p < 0.0001), and PRBC use (OR 1.04/unit,
p < 0.0001). Visceral perfusion was associated with modestly increased risk
(OR 1.3, p < 0.04) among patients with aneurysm extents (TAA 1, 2, and 4)
involving the visceral vessels. Incidence of renal dysfunction has risen
gradually over time. Long-term survival is strongly inﬂuenced by post-
operative renal failure (Figure, p < 0.0001).
Conclusion: New-onset renal dysfunction is common after thoraco-
abdominal aortic surgery, and is strongly associated with reduced long-
term survival. Renal protection strategies are urgently needed, and treat-
ments that can reduce the effects of ischemic time and transfusion are
likely intervention targets.
Acute Endovascular Repair of Ruptured Thoraco-abdominal
Aneurysms with Branched Stentgrafts
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Introduction: Endovascular repair of thoraco-abdominal aneurysms with
branched stent grafts (bEVAR) has shown promising results in the elec-
tive situation. Off the shelf devices have been introduced recently
allowing endovascular treatment of TAAA in the acute setting, including
rupture (rTAAA). However, very little is known about acute bEVAR for the
treatment of rTAAA. Our aim is to report the results of acute bEVAR in
patients with rTAAA.
Methods: A retrospective review of patients undergoing acute bEVAR
between 2008 and April 2015 in a single centre with large experience of the
elective procedures. Stent grafts used consisted mostly of off the shelf
endograft with 4 caudally oriented branches. Spinal drainage use was
decided depending on the emergency character of the operation. Values
are presented as median and range when not stated otherwise.
Results: 10 patients, (5 males, 64 (34e77) years old) underwent
bEVAR during the study period. TAAA had a median pre-operative
diameter of 70 (57- 90) mm and the anatomy according to Crawford was:
2 type I, 4 type II, 3 type III and 1 type IV. Median operative time was
436 (245e785) minutes. Endovascular conduit had to be used in 2 pa-
tients. Six patients had all 4 visceral arteries incorporated in the repair
while 2 and 1 patient had 3 and 2 arteries, respectively. One patient died
intra-operatively before the branches could be extended, making the
immediate technical success 90 % (n ¼ 9). Two more patients died within
30 days of bEVAR (30 day mortality of 30 %). Four of the nine patients
surviving bEVAR (44%) developed signs of post-operative spinal cord
ischemia. Three of the patients recovered completely while one devel-
oping the symptoms 4 days after bEVAR remained paraplegic. The 7
patients surviving more than 30 days were followed-up for 13 (1 e38)
months). During this period only one patient died of unrelated causes.
During the CT follow up (median of 13 (1e38) months) no aneurysms
expanded. One patient underwent an arch repair 9 months post-
